Vanguard Personalized Indexing Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
VCM
OFM
LCM
DFO
Vanguard Personalized Indexing Management's NUVB Position: Q1 2026 in Review
Vanguard Personalized Indexing Management reduced its Nuvation Bio (NUVB) stake by 3.5% in Q1 2026, selling an estimated $7.02K and leaving 34,823 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #1884.
Vanguard Personalized Indexing Management first reported a position in NUVB in Q4 2023 and has held it in 10 quarters since. The position peaked at $323K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.
- Vanguard Personalized Indexing Management held 34,823 shares of Nuvation Bio worth $149K as of Q1 2026.
- Vanguard Personalized Indexing Management sold 1,260 Nuvation Bio shares in Q1 2026, an estimated $7.02K.
- Nuvation Bio made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1884 holding.
- Vanguard Personalized Indexing Management first reported a position in Nuvation Bio in Q4 2023 and has held it in 10 quarters since.
- Vanguard Personalized Indexing Management's Nuvation Bio position peaked at $323K in Q4 2025.
- 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.
Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.